Immunotherapies for hepatocellular carcinoma

Josep M. Llovet; Florian Castet; Mathias Heikenwälder; Mala K. Maini; Vincenzo Mazzaferro; David J. Pinato; Eli Pikarsky; Andrew X. Zhu; Richard S. Finn

doi:10.1038/s41571-021-00573-2

Related publications

Article2024

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn

Nature Reviews Clinical Oncology

Article2021

Hepatocellular carcinoma

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman‐Rossi, Richard S. Finn

Nature Reviews Disease Primers

Chapter in a book2006

Hepatocellular Carcinoma

Jordi Bruix, C. Bru, Josep M. Llovet

Article2016

Hepatocellular carcinoma

Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, Bruno Sangro, M. Schwartz, Morris Sherman, Gregory J. Gores

Nature Reviews Disease Primers

Article2014

Genome-scale metabolic models for hepatocellular carcinoma

Roser Pinyol, Josep M. Llovet

Nature Reviews Gastroenterology & Hepatology

Immunotherapies for hepatocellular carcinoma

Abstract

Discussion(0)

Related publications

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Hepatocellular carcinoma

Hepatocellular Carcinoma

Hepatocellular carcinoma

Genome-scale metabolic models for hepatocellular carcinoma